New anesthesia drug checked for heart risks in healthy adults
NCT ID NCT06795204
First seen Jan 16, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This completed Phase 1 study tested whether a single dose of HSK3486, an anesthesia drug, affects the heart's electrical activity (QTc interval) in 48 healthy adults aged 18 to 45. Participants received either the drug, a placebo, or a positive control to compare effects. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Gobroad Boren Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.